
Jazz Pharmaceuticals plc JAZZ
$ 135.62
-0.75%
Quarterly report 2024-Q3
added 11-07-2024
Country |
![]() |
IPO year |
2007 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Bruce Cozadd |
Employees in the company |
1 620 |
Shares |
63.3 M |
Market Cap[1] |
$ 8.58 B |
EBITDA (LTM) |
$ 1.17 B |
P/E (LTM) |
14.47 |
P/S (LTM) |
1.92 |
EPS (LTM) |
8.28 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.